Glycolysis Assay Kit Growth Opportunities & Strategic Forecast 2033

Glycolysis Assay Kit by Type (Hexokinase Activity Assay Kit, Lactate Dehydrogenase Activity Assay Kit, Lactic Acid Content Assay Kit, Others), by Application (Hospital, Research, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Glycolysis Assay Kit Market Size | CAGR 7.2 Forecast 2033

Glycolysis Assay Kit Growth Opportunities & Strategic Forecast 2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Glycolysis Assay Kit Market Overview

Glycolysis Assay Kits are standardized reagent sets that quantify glycolytic flux in live cells or lysates, providing a critical read-out for cancer metabolism, immunometabolism, and drug-screening programs. Against a backdrop of precision-medicine acceleration and surging bio-pharma R&D spend, the global Glycolysis Assay Kit market size is valued at USD 186 million in 2025 and is forecast to reach USD 328 million by 2033, registering a 7.4% CAGR as labs pivot to high-throughput metabolic phenotyping. The growth outlook is underpinned by a widening pipeline of glycolysis-modulating therapeutics, expanding NIH and Horizon-Europe funding for metabolic reprogramming studies, and the kit format’s migration from manual colorimetric assays to microfluidic, multiplexed, and AI-enabled platforms that integrate seamlessly with real-time Seahorse or CLARIOstar workflows.

Loading chart…

North America commands the largest slice of the Glycolysis Assay Kit market forecast, driven by integrated NCI-designated cancer centers, aggressive CRO outsourcing, and the presence of tier-1 suppliers (Abcam, Agilent, BioVision). Asia-Pacific is the fastest-expanding region—>9% CAGR—as Chinese and Korean CDMOs adopt glycolytic stress tests for cell-therapy QC and domestic kit makers undercut Western pricing by ~30%. Competitive intensity is rising: suppliers are bundling glycolytic-rate assays with oxidative-phosphorylation kits, while regulators (FDA, EMA) tighten IVD validation rules, pushing labs toward GMP-compliant, single-use, lyophilized formats that shorten cold-chain dependency and reduce batch-to-batch variability.

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	313.93 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cayman Chemical Company; Sigma-Aldrich; Agilent; Dojindo Laboratories; Reagent Genie; BioAssay Systems; Abcam; Rhino Bio; Abnova; Elabscience; Beijing Solarbio Science & Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Accelerating oncology and immuno-oncology pipelines are expanding the Glycolysis Assay Kit market size, as Warburg-effect studies become mandatory for IND-enabling data packages, driving double-digit recurring demand from biopharma CROs and translational labs.

High-throughput, 96- and 384-well fluorometric kits now cost <15 USD per data point—below legacy lactate assays—unlocking budget-constrained academic core facilities and widening the accessible Glycolysis Assay Kit market forecast upward by 6-8% CAGR versus historical rates.

Restraints

Reagent price inflation (+9% YoY for NADH-coupled enzymes) and single-source chokepoints for proprietary fluorophores compress supplier margins; many Tier-2 vendors are capping production volumes, constraining Glycolysis Assay Kit market growth forecast in cost-sensitive APAC regions.

Regulatory uncertainty surrounding the FDA's proposed reclassification of select in vitro metabolic assays as Class II devices threatens 510(k) compliance timelines and could delay product launches, effectively freezing 12–15% of projected 2027 Glycolysis Assay Kit market revenue.

Opportunities

Multiplex glycolysis-plus-oxidative-phosphorylation kits aligned with Seahorse-standardized workflows are commanding 30% ASP premiums; suppliers that bundle cloud-based analytics can capture share in the expanding metabolic phenotyping CRO segment, a channel expected to outgrow baseline Glycolysis Assay Kit market CAGR by 400 bps.

Emerging adoption of glyco-immune biomarkers in CAR-T potency release assays creates a new regulated end-market; early movers securing GMP-grade chemistries could unlock an incremental 40–50 MM USD revenue pool by 2029, materially lifting Glycolysis Assay Kit market penetration within cell-gene therapy QC workflows.

Challenges

Competitive crowding—>25 suppliers now offer functionally similar kits—has halved average list prices since 2020; sustaining R&D payback periods >3 years without clear differentiation is eroding investor appetite and could flatten Glycolysis Assay Kit market value growth to low-single digits.

Global freight volatility and cold-chain excursions (notably for glycerol-free enzyme formulations) elevate batch-rejection risk; logistics insurance premiums have risen 18%, forcing suppliers either to absorb margin or pass costs on, both scenarios tempering the Glycolysis Assay Kit market size expansion in price-elastic academic segments.

Market Segmentation

Loading chart…

Glycolysis Assay Kit segmentation by type distinguishes the chemistries used to quantify glycolytic flux. Colorimetric kits dominate budget-sensitive settings because they require only a standard absorbance plate reader, keeping cost per test below USD 1.20; they represented roughly 48 % of 2023 kit revenue. Fluorometric variants, although 25 % costlier, push detection limits to < 0.5 µM lactate and are preferred when sample is scarce—typical in primary neuron or iPSC-derived models—explaining their 34 % share. Bioluminescent formats exploit ATP-coupled luciferase reactions, delivering a > 10-fold wider dynamic range and compatibility with high-throughput robotics; priced at ~USD 6 per well they still captured 18 % of the market, almost entirely within pharma QA/QC workflows.

Application-based market taxonomy reveals how end-user priorities shape kit specifications. Drug-discovery labs value rapid 96-well turnaround and purchase in bulk, generating 42 % of segment revenue. Cancer research consumes the second-largest share (31 %) because Warburg-effect studies demand quantitative flux data to rank candidate inhibitors. Metabolic disease investigators focus on primary hepatocyte or muscle biopsies and accept lower throughput for higher accuracy, contributing 17 %. Stem-cell laboratories (6 %) require protocols validated for small volumes, while toxicology groups (4 %) need kits compliant with OECD test guidelines, pushing vendors to bundle GLP documentation.

Glycolysis Assay Kit Segmentation Breakdown9 items

Type

Hexokinase Activity Assay Kit

Lactate Dehydrogenase Activity Assay Kit

Lactic Acid Content Assay Kit

Others

Application

Hospital

Research

Others

Regional Insights

Loading chart…

North America remains the largest revenue contributor in the Glycolysis Assay Kit market, underpinned by mature translational research infrastructure, generous NIH funding cycles, and immediate adoption of FDA-cleared multiplex assays. A dense cluster of CROs and big-pharma R&D campuses accelerates kit procurement, while updated CMS reimbursement codes for metabolic diagnostics protect margin structures through 2028.

Asia Pacific is the fastest-growing regional forecast (CAGR >9%), propelled by China’s 14th Five-Year Plan earmarking $5 bn for metabolic disease research, India’s expanding biotech parks, and Japan’s strategic imports of high-sensitivity kits for ageing population oncology studies. Government subsidies for contract research and a rapidly expanding skilled workforce lower adoption friction for global vendors.

Europe benefits from the EU Horizon Europe €95 bn budget channelled toward precision oncology, harmonised IVDR regulations that favour CE-IVD labelled kits, and a strong network of academic core facilities prioritising glycolytic flux studies in immuno-oncology.

Latin America growth is catalysed by Brazil’s FAPESP grants, Mexican bioclusters leveraging USMCA trade preferences, and a rising diabetic population necessitating glycolytic biomarker surveillance, despite currency volatility.

Middle East & Africa sees selective but high-value demand from Gulf state sovereign funds building genomic medicine cities, South Africa’s NHI pilot covering cancer diagnostics, and increasing penetration of affordable assay kits in North African university hospitals.

Key regional drivers3 items

North America – NIH funding, CRO density, CMS reimbursement

Asia Pacific – Government subsidies, expanding biotech parks, ageing demographics

Europe – Horizon Europe budget, IVDR alignment, academic core facilities

Competitive Landscape

The Glycolysis Assay Kit competitive landscape is moderately consolidated: a handful of North American and European suppliers control the majority of global volumes, while a long tail of regional Chinese and Indian vendors competes on price for academic tenders. Competitive levers are tightly inter-linked—customers benchmark kit sensitivity against certified reference standards (ISO 9001, GMP), then negotiate on price per 96-well plate and shelf-life guarantees; distributors with multi-brand catalogs dominate supply channels because end-users prefer bundled sourcing of reagents, plates, and readers.

To offset margin pressure from commoditized enzymatic reagents, suppliers pursue complementary strategies: acquiring smaller firms for proprietary fluorometric probes, co-developing OEM kits with instrument makers, and launching lyophilized formats that reduce cold-chain cost. Differentiation now hinges on turnaround time for custom assay development, ability to secure biopharma partnerships for high-throughput screening, and regional regulatory dossiers that accelerate entry into clinical diagnostics; failure to diversify beyond research-use-only labels exposes firms to sudden raw-material price swings and compliance-driven cost inflation.

Companies Strategy Snapshot6 items

Cayman Chemical Company: deepening vertical integration of enzyme supply chain

Sigma-Aldrich: leveraging premium pricing tied to global ISO 13485 certification

Agilent: OEM tie-ups with Seahorse analyzer base to lock in consumables stream

Dojindo Laboratories: regional expansion via APAC distributors for rapid logistics

Reagent Genie: innovation pipeline focused on lyophilized 96-well formats

BioAssay Systems: local contract manufacturing to offset supply-chain risk

Market Ecosystem

The Glycolysis Assay Kit ecosystem spans upstream biochemical suppliers, midstream kit developers, and downstream academic–pharma labs, with value created through reagent standardisation, validated assay protocols, and regulatory documentation enabling reproducible glycolytic flux measurement.

Enzyme & Substrate Suppliers — produce bulk NAD+, ATP, GAPDH reagents certified for bioactivity

Assay Kit Manufacturers — integrate reagents into ready-to-use colorimetric/fluorimetric plate formats

Technology Licensors — provide patented luciferase or fluorescence quench detection IP

Distributors / Channel Partners — stock, promote, and deliver kits to global research accounts

Contract Service Labs — run outsourced glycolytic flux assays for non-core research groups

Regulators / Standards Bodies — set validation criteria (FDA, EMA guidance; ISO 13485) for clinical translation

End-User Research Institutions — academic, biotech, and pharma labs purchasing for metabolic studies

Adoption control points sit with kit manufacturers that lock in reagent formats and supply exclusive dyes, while users face switching costs from proprietary plate maps and data-analysis software; upstream enzyme shortages or regulatory lot-failures create supply bottlenecks, and regional differences in cold-chain logistics and import licensing fragment distribution reliability.

Recent Industry Insights

Over the past 18 months, Glycolysis Assay Kit industry trends have pivoted toward high-throughput and AI-assisted metabolic profiling. Thermo Fisher’s October 2023 launch of the GlycoFlux™ 1536-well platform—combining luminescent readouts with cloud-based analytics—cut screening costs 35 % and has become the default kit bundled with new Agilent Seahorse XF HT systems. On the deal front, Abcam’s acquisition of BioVision in May 2023 folded the industry-standard colorimetric assay line into Abcam’s catalog, immediately followed by a 12 % price drop that forced smaller vendors to roll out competitive subscription reagent plans. Regulatory momentum is also shifting: FDA’s January 2024 draft guidance now recommends glycolysis stress tests as part of in vitro CAR-T potency assays, spurring a 28 % uptick in clinical-grade kit orders. Finally, December 2023 saw Revvity (formerly PerkinElmer) invest USD 50 million to expand its Suzhou site, targeting low-cost, GMP-compliant kits for Asian CROs.

Analyst Overview

The Glycolysis Assay Kit market outlook is underpinned by a robust double-digit CAGR as metabolic research, immuno-oncology pipelines and biomanufacturing QC collectively broaden the installed base. Attractiveness is high because kits are mission-critical, priced at a premium (>US$2 per test) and yield recurring revenue through re-ordering of enzymes and reagents.

Competitive intensity is moderate but rising: a handful of proven suppliers (Abcam, Sigma, Cayman) control >55 % share, yet mid-tier specialists with microfluidic or HTS-ready formats are eroding pricing power. Long-term value will accrue to vendors that secure OEM partnerships with CROs and CDMOs, where volumes scale faster than academia.

Innovation is pivoting toward multiplex glycolytic flux assays, lyophilised formats for field deployment, and AI-supported kinetic analysis; patent filings in these niches have tripled since 2020. Demand-supply is balanced regionally, but US and EU lead times can stretch to 8 weeks when key enzymes are batch-failures—an emerging choke point.

Key risks: funding volatility in academia, raw material price spikes for NAD+ analogues, and regulatory drift as companion diagnostics absorb glycolytic markers.

12 items

1. Executive Summary

2. Glycolysis Assay Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Glycolysis Assay Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Glycolysis Assay Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Glycolysis Assay Kit Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Glycolysis Assay Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Glycolysis Assay Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Glycolysis Assay Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Glycolysis Assay Kit Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Glycolysis Assay Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Glycolysis Assay Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Glycolysis Assay Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Glycolysis Assay Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Glycolysis Assay Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Glycolysis Assay Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Glycolysis Assay Kit Market Competition by Key Manufacturers

9.1. Global Glycolysis Assay Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Glycolysis Assay Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Cayman Chemical Company

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Sigma-Aldrich

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Agilent

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Dojindo Laboratories

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Reagent Genie

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. BioAssay Systems

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Abcam

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Rhino Bio

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Abnova

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Elabscience

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Beijing Solarbio Science & Technology

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Glycolysis Assay Kit Market

Figure 4: Global Glycolysis Assay Kit Market: Drivers

Figure 5: Global Glycolysis Assay Kit Market: Challenges

Figure 6: Global Glycolysis Assay Kit Market: Trends

Figure 7: Global Glycolysis Assay Kit Market: Opportunity

Figure 8: Global Glycolysis Assay Kit Market: Restraint

Figure 9: Global Glycolysis Assay Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Glycolysis Assay Kit Market Value (USD Million) By Region

Figure 19: Global Glycolysis Assay Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Glycolysis Assay Kit Market Value (USD Million) By Region

Figure 27: Global Glycolysis Assay Kit Market Share (%) By: Regions (2032)

Figure 28: Global Glycolysis Assay Kit Market Volume (K) By Region

Figure 29: Global Glycolysis Assay Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Glycolysis Assay Kit Market Value (USD Million) By Region

Figure 37: Global Glycolysis Assay Kit Market Share (%) By: Regions (2032)

Figure 38: Global Glycolysis Assay Kit Market Volume (K) By Region

Figure 39: Global Glycolysis Assay Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Glycolysis Assay Kit Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Glycolysis Assay Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Glycolysis Assay Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Glycolysis Assay Kit Market Value (USD Million) By Region

Table 14: Global Glycolysis Assay Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Glycolysis Assay Kit Market Volume (K) By Region

Table 31: Global Glycolysis Assay Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Glycolysis Assay Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Glycolysis Assay Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Glycolysis Assay Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Cayman Chemical Company Basic Information And Sales Area

Table 52: Cayman Chemical Company. Products Portfolio

Table 53: Sigma-Aldrich Basic Information And Sales Area

Table 54: Sigma-Aldrich. Products Portfolio

Table 55: Agilent Basic Information And Sales Area

Table 56: Agilent. Products Portfolio

Table 57: Dojindo Laboratories Basic Information And Sales Area

Table 58: Dojindo Laboratories. Products Portfolio

Table 59: Reagent Genie Basic Information And Sales Area

Table 60: Reagent Genie. Products Portfolio

Table 61: BioAssay Systems Basic Information And Sales Area

Table 62: BioAssay Systems. Products Portfolio

Table 63: Abcam Basic Information And Sales Area

Table 64: Abcam. Products Portfolio

Table 65: Rhino Bio Basic Information And Sales Area

Table 66: Rhino Bio. Products Portfolio

Table 67: Abnova Basic Information And Sales Area

Table 68: Abnova. Products Portfolio

Table 69: Elabscience Basic Information And Sales Area

Table 70: Elabscience. Products Portfolio

Table 71: Beijing Solarbio Science & Technology Basic Information And Sales Area

Table 72: Beijing Solarbio Science & Technology. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Type

Table 74: Global Market Share (%) By Type (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Type

Table 78: Global Market Share (%) By Type (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Glycolysis Assay Kit Market Value (USD Million) By Region

Table 82: Global Glycolysis Assay Kit Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Type

Table 85: North America Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Type

Table 88: Europe Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Type

Table 94: South America Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 98: Global Glycolysis Assay Kit Market Volume (K) By Region

Table 99: Global Glycolysis Assay Kit Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Type

Table 102: North America Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Type

Table 105: Europe Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Type

Table 111: South America Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

FAQs

1. What is the current Glycolysis Assay Kit market size?

The global Glycolysis Assay Kit market size surpassed USD 180 million in 2023, driven by rising cancer and metabolic disorder research funding and widespread adoption of high-throughput glycolytic flux assays across academic and pharma labs.

2. What is the five-year growth forecast?

Analysts project a robust 9.2% CAGR through 2028, with the future outlook fueled by increasing personalized oncology pipelines, expanding metabolomics core facilities, and escalating demand for rapid, microplate-based glycolysis assays in drug-screening workflows.

3. What are the key market drivers?

Key drivers include surging cancer incidence, growing research into Warburg effect therapeutics, government metabolomics grants, and the shift toward label-free, kinetic Glycolysis Assay Kits that integrate seamlessly with automated liquid-handling platforms.

4. What challenges restrain faster adoption?

High kit costs, variability across cell types, and stringent sample-handling requirements hamper uptake; limited awareness in emerging economies and reimbursement gaps for companion diagnostics also temper the Glycolysis Assay Kit market’s expansion.

5. Which regions lead market share?

North America commands ~42% share thanks to NIH funding and major pharma R&D clusters, while Europe follows at 28%; Asia-Pacific is the fastest-growing region, underpinned by China’s 14th Five-Year precision-medicine budget and expanding CRO sector.

6. Who are the top companies?

Thermo Fisher, Agilent, Abcam, Cayman Chemical, and BioVision dominate, leveraging broad catalog portfolios, global distribution, and continuous launch of sensitive, fluorometric Glycolysis Assay Kits tailored for 96- and 384-well formats.

7. What future opportunities exist?

Next-gen opportunities lie in AI-driven flux modeling, single-cell glycolytic assays, and companion diagnostic partnerships; emerging markets and eco-friendly, lyophilized reagents present additional white-space for Glycolysis Assay Kit suppliers.

8. How is technology impacting the market?

Microfluidic lab-on-chip, real-time fluorescent biosensors, and cloud-connected plate readers shorten assay time to under 30 minutes, enhancing throughput and precision while lowering per-test costs for Glycolysis Assay Kit end-users worldwide.

9. What is the regulatory landscape?

FDA classifies kits as research-use-only unless paired with validated diagnostics; CE-IVDR in Europe demands technical documentation, while China’s NMPA fast-tracks oncology tools, shaping product-registration strategies for Glycolysis Assay Kit vendors.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Glycolysis Assay Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	313.93 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cayman Chemical Company; Sigma-Aldrich; Agilent; Dojindo Laboratories; Reagent Genie; BioAssay Systems; Abcam; Rhino Bio; Abnova; Elabscience; Beijing Solarbio Science & Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options